![Kelly Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Gold
Financieel Directeur/CFO bij
CAMP4 THERAPEUTICS CORPORATION
Vermogen: 342 409 $ op 31-08-2026
Profiel
Kelly Gold is currently Director & Director-Individual Fundraising at Education First, Independent Director at X4 Pharmaceuticals, Inc. starting in 2026, and Chief Financial Officer at CAMP4 Therapeutics Corp.
since 2022.
Former roles include Associate Director-Strategic Corporate Finance at Biogen, Inc. from 2014 to 2017 and Partner at Deutsche Bank AG (New York Branch) from 2009 to 2013.
Education includes an undergraduate degree from Queen's University and an MBA from MIT Sloan School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-08-2026 | 86.467 ( 0,18% ) | 342 409 $ | 31-08-2026 |
Actieve functies van Kelly Gold
| Bedrijven | Functie | Begin |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Financieel Directeur/CFO | 01-04-2022 |
| X4 PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-06-2026 |
Education First
 Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kelly Gold
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2017 |
Deutsche Bank AG (New York Branch)
 Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Kelly Gold
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Deutsche Bank AG (New York Branch)
Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Education First
Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Miscellaneous |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
